COVID-19

>

Latest News

FDA approves NVX-CoV2705 COVID-19 vaccine | Image credit: Contemporary Pediatrics
FDA approves NVX-CoV2705 COVID-19 vaccine

May 19th 2025

NVX-CoV2705 is indicated for individuals aged 12 to 64 years with an underlying condition that poses high risk for severe COVID-19 outcomes.

The pediatric mental health crisis: A call to action for pediatricians | Image Credit: © Seventyfour - © Seventyfour - stock.adobe.com.
The pediatric mental health crisis: A call to action for pediatricians

March 5th 2025

COVID-19 Roundtable: Prophylaxis for the immunocompromised
COVID-19 Roundtable: Prophylaxis for the immunocompromised

December 24th 2024

No unexpected reactions present in mRNA COVID-19 vaccination among kids | Image Credit: © angellodeco - © angellodeco - stock.adobe.com.
No unexpected reactions present among mRNA COVID-19 vaccination in kids

November 27th 2024

Weekly report: Phase 3 data for JNJ2113, expert discussions, and more

November 25th 2024

Video Series
Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.